Crossmark

Quizartinib elicits differential responses that correlate with karyotype and genotype of the leukemic clone

Published Online: 2015-11-20

Published Print: 2016-06

Authors

Nybakken, G E

Canaani, J

Roy, D

Morrissette, J D

Watt, C D

Shah, N P

Smith, C C

Bagg, A

Carroll, M

Perl, A E
License Information

Text and Data Mining valid from 2015-11-20

Version of Record valid from 2015-11-20
More Information

Article History

First Online: 20 November 2015

Competing interests

: AEP has served as a consultant to Ambit Biosciences, Astellas Pharmaceuticals and Arog Pharmaceuticals. CCS received clinical trial grant funding from Astellas. The remaining authors declare no conflict of interest.

Document is current